These outcomes, along with a past report showing that a small-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like behavior in mice,two aid the thought of focusing on ACKR3 as a singular approach to modulate the opioid program, which could open new therapeutic avenues for opioid-similar Issues.Notice: Results may possibly differ about any item ef